Stock News

Real-time ticker analysis, price-action alerts, and institutional-grade stock data.

LNG
$284.40+0.05%
4/7, 6:51 AM

Golar LNG Limited – Q1 2026 results presentation

Golar LNG's 1st Quarter 2026 results will be released before the market opens on Wednesday, May 20, 2026. In connection with this a webcast presentation will be held at 08:00am Eastern Time (1:00pm London Time) on Wednesday May 20, 2026. The presentation will be available to download from the Investor Relations section at www.golarlng.com

globenewswire.comView Stock
ANIP
$83.69+5.31%
4/7, 6:50 AM

ANI Pharmaceuticals Announces Publication of NEW DAY Clinical Trial Results in Ophthalmology

PRINCETON, N.J., April 07, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced publication of the results from the NEW DAY clinical trial involving ILUVIEN® (fluocinolone acetonide intravitreal implant), 0.19 mg (ILUVIEN) for use in appropriate patients with diabetic macular edema in Ophthalmology, the journal of the American Academy of Ophthalmology. The company previously announced results from the NEW DAY trial in July 2025. ILUVIEN is a corticosteroid indicated for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure.

globenewswire.comView Stock
LQDT
$32.99+4.56%
4/7, 6:50 AM

Liquidity Services Announces Second Quarter Fiscal Year 2026 Earnings Conference Call

BETHESDA, Md., April 07, 2026 (GLOBE NEWSWIRE) -- Liquidity Services (NASDAQ:LQDT), the leading global provider of e-commerce marketplaces and software solutions powering the circular economy, today announced that it expects to report its second quarter fiscal year 2026 results prior to market open on Thursday, May 7, 2026. Bill Angrick, Chairman and CEO, and Jorge Celaya, EVP and CFO, will then host a conference call to review the results at 10:30 AM Eastern Time.

globenewswire.comView Stock
OKTA
$80.20+1.08%
4/7, 6:47 AM

Okta: I Am Still Expecting Growth To Accelerate

Okta earns a buy rating, with platform expansion and new product traction driving bullish conviction despite near-term growth concerns. Newer products now comprise ~30% of Q4 bookings, with ~40% average contract uplift, signaling deeper customer penetration and expanding revenue per client. AI agent identity management is emerging as a significant future growth vector, positioning OKTA to benefit from increasing enterprise adoption of non-human identities.

seekingalpha.comView Stock
NVO
$37.10+0.51%
4/7, 6:46 AM

Novo Nordisk A/S – Share repurchase programme

Bagsværd, Denmark, 7 April 2026 – On 4 February 2026, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 15 billion to be executed during a 12-month period beginning 4 February 2026.

globenewswire.comView Stock
SR
$121.77+29.90%
4/7, 6:45 AM

Spire Advances Agriculture Intelligence with Integrated Soil Moisture Data and Weather Forecasts

VIENNA, Va.--(BUSINESS WIRE)--Spire Global, Inc. (NYSE: SPIR) (“Spire” or “the Company”), a global provider of satellite data, analytics and intelligence, announced its expanded agriculture intelligence offering with integrated soil moisture data and weather forecasting capabilities. The solution delivers a continuous “past-present-future” soil moisture and weather intelligence framework, integrating more than 40 years of historical records with daily satellite observations, site-specific forec.

businesswire.comView Stock
OXLC
$9.78+0.72%
4/7, 6:38 AM

OXLC Is A Mess - Here's Why I'm Bullish

OXLC's business model shifts credit risk to shareholders, distributing all earnings and recording capital losses as NAV/share declines. Returns are positively correlated with price/NAV discounts, favoring buy-and-hold entry at deep discounts. The 2032 7.9% Notes now trade below redemption, offering fixed-income investors a cleaner, lower-risk exit.

seekingalpha.comView Stock

ASML stock tumbles as US bill threatens China chip tool sales

ASML shares fell 2.6% on Tuesday after a group of bipartisan US lawmakers introduced legislation last week that could further restrict the Dutch semiconductor equipment maker's already constrained sales to China. The bill, if passed, would extend export controls to include less advanced chipmaking tools that Chinese manufacturers have so far been permitted to buy.

invezz.comView Stock
CASH
$93.99+1.49%
4/7, 6:32 AM

SASOL FINANCING USA LLC ANNOUNCES RESULTS OF CASH TENDER OFFER FOR ANY AND ALL OUTSTANDING DEBT SECURITIES

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO, OR TO ANY PERSON RESIDENT AND/OR LOCATED IN, ANY JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION IS UNLAWFUL  JOHANNESBURG, April 7, 2026 /PRNewswire/ -- Sasol Financing USA LLC (NYSE: SSL) ("Sasol" or the "Company") announced today the results of its previously announced tender offer (the "Any and All Tender Offer") to purchase for cash any and all of its outstanding 6.500% Notes due 2028 (the "2028 Notes"). The Any and All Tender Offer is being made pursuant to the terms and conditions set forth in the Offer to Purchase dated March 30, 2026 (the "Offer to Purchase") and the related Notice of Guaranteed Delivery.

prnewswire.comView Stock
BOSS
$25.75-0.14%
4/7, 6:30 AM

BOSS Zhipin Continues Share Repurchases, with Total Repurchases Amounting to Nearly RMB700 Million in 2026

BEIJING, April 07, 2026 (GLOBE NEWSWIRE) -- KANZHUN LIMITED (“BOSS Zhipin” or the “Company”) (Nasdaq: BZ; HK: 2076) today announced the continued execution of its share repurchase program, utilizing around RMB55.0 million to repurchase 1,180,162 ordinary shares on April 2 and April 6. Year-to-date in 2026, the Company has deployed nearly RMB700 million toward share repurchases. This move underscores the Company's ongoing commitment to shareholder returns.

globenewswire.comView Stock
NUVL
$107.56+5.19%
4/7, 6:30 AM

Nuvalent Announces Submission of New Drug Application to FDA for Neladalkib in TKI Pre-treated Advanced ALK-positive NSCLC

New Drug Application (NDA) based on data in TKI pre-treated patients from the global ALKOVE-1 Phase 1/2 clinical trial CAMBRIDGE, Mass., April 7, 2026 /PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced the submission to the U.S. Food and Drug Administration (FDA) of the Company's NDA for neladalkib, an investigational ALK-selective inhibitor, in TKI pre-treated advanced ALK-positive NSCLC.

prnewswire.comView Stock
BJDX
$2.12+3.41%
4/7, 6:30 AM

Bluejay Diagnostics, Inc. Announces Completion of 624 Patient Enrollments in SYMON-II Pivotal Clinical Trial

ACTON, Mass., April 07, 2026 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (“Bluejay” or the “Company”), a medical diagnostics company focused on rapid, near-patient testing, today announced the successful enrollment of 624 patients in its ongoing SYMON-II Trial, a pivotal clinical study evaluating the Company's Symphony™ platform for interleukin-6 (IL-6) testing in critical care settings to determine patient acuity for sepsis triage and monitoring.

globenewswire.comView Stock
USV
$31.75-7.22%
4/7, 6:30 AM

Kraken Robotics Demonstrates KATFISH Autonomous Launch and Recovery from SEFINE USV

ST. JOHN'S, Newfoundland and Labrador, April 07, 2026 (GLOBE NEWSWIRE) -- Kraken Robotics Inc. (“Kraken” or the “Company”) (TSX-V: PNG, OTCQB: KRKNF) announces the successful integration and demonstration of its KATFISH towed synthetic aperture sonar and autonomous launch and recovery system (LARS) from SEFINE's RD-22 unmanned surface vessel (USV) in coordination with SEFINE SISAM (Strategic Unmanned Systems Research Center). The demonstration took place in Q1 2026 off the coast of İstanbul, Türkiye.

globenewswire.comView Stock
NIQ
$12.76+10.29%
4/7, 6:30 AM

Reckitt Accelerates Innovation with NIQ AI Insights, reporting up to 65% faster research

CHICAGO--(BUSINESS WIRE)-- #AI--NIQ (NYSE: NIQ), a global leader in consumer intelligence, today shared new results from Reckitt's use of NIQ BASES AI Screener, demonstrating how AI-powered insights and synthetic data are transforming innovation speed and effectiveness. The case study highlights how Reckitt has accelerated concept development while improving performance outcomes—bringing more relevant products to market, faster. As companies face growing pressure to innovate quickly in an increasingl.

businesswire.comView Stock
MKTX
$183.60+4.46%
4/7, 6:30 AM

MarketAxess Announces Trading Volume Statistics for March and First Quarter 2026

NEW YORK--(BUSINESS WIRE)--MarketAxess Holdings Inc. (Nasdaq: MKTX), the operator of a leading electronic trading platform for fixed-income securities, today announced trading volume and preliminary variable transaction fees per million (“FPM”) for March 2026 and the first quarter ended March 31, 2026.1 Trading Records for March 2026 Total credit average daily volume ("ADV") Open Trading® ADV Total portfolio trading ADV U.S. high-grade ADV U.S. high-grade block trading ADV U.S. high-grade portf.

businesswire.comView Stock
BWMN
$31.58+6.33%
4/7, 6:19 AM

Bowman Consulting: Capturing Utility Growth Without Paying A Premium

Bowman Consulting offers a compelling, underappreciated play on the electrification boom, with increasing exposure to utilities and data centers. BWMN's backlog in utilities has grown from 13% in 2022 to 24% in 2025, supporting revenue growth and margin expansion. Despite sector headwinds, BWMN posted 2025 revenues of $420 million and expects $496–$510 million in 2026, with adjusted EBITDA margin rising to 17–17.5%.

seekingalpha.comView Stock
CLOI
$52.62+0.23%
4/7, 6:12 AM

CLOI: Buy The Complexity Premium Before It Disappears

VanEck CLO ETF earns a buy rating for its dynamic allocation across IG CLO tranches, offering a compelling blend of yield and risk control. CLOI's active management by PineBridge enables opportunistic rotation, capturing a persistent 50–150 bps complexity premium over comparable corporate credit with minimal duration risk. The fund's floating-rate structure, strong diversification, and near-zero equity beta make it an effective non-correlated income sleeve as Fed policy normalizes.

seekingalpha.comView Stock
HMH
$18.25+0.00%
4/7, 6:12 AM

HMH (NASDAQ:HMH) Insider Roy Dyrseth Acquires 8,000 Shares

HMH Holding Inc (NASDAQ: HMH - Get Free Report) insider Roy Dyrseth purchased 8,000 shares of the stock in a transaction dated Thursday, April 2nd. The shares were purchased at an average cost of $20.00 per share, for a total transaction of $160,000.00. Following the completion of the acquisition, the insider directly owned 68,276 shares in

defenseworld.netView Stock
QQQX
$27.85+0.61%
4/7, 6:12 AM

QQQX: Generates Income From The Current Uncertainty Of AI

Nuveen Nasdaq 100 Dynamic Overwrite Fund remains a buy, offering an 8.9% yield and trading at a 4.46% discount to NAV. QQQX's option-writing strategy delivers reliable income and reduced volatility, outperforming during sideways markets but capping long-term upside versus traditional growth ETFs. The fund's payouts are well covered by earnings, with 2025 earnings of $3.75 per share versus $2.24 in distributions, supporting income sustainability.

seekingalpha.comView Stock
KALV
$20.70+2.88%
4/7, 6:11 AM

KalVista Pharmaceuticals: Ekterly's Launch Momentum Keeps The Bull Case Alive

KalVista Pharmaceuticals is now a commercial rare-disease play with Ekterly established as the first oral on-demand HAE therapy across seven approved markets. I think Ekterly's convenience versus injectables supports future adoption. Repeat refills have also been a favorable tailwind. Looking ahead, Ekterly's potential pediatric expansion into ages 2 to 11 could add meaningful upside.

seekingalpha.comView Stock
NFLX
$99.07+0.25%
4/7, 6:08 AM

Bank of Stockton Grows Stake in Netflix, Inc. $NFLX

Bank of Stockton boosted its position in Netflix, Inc. (NASDAQ: NFLX) by 897.6% in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 26,785 shares of the Internet television network's stock after purchasing an additional 24,100 shares during the period. Netflix comprises

defenseworld.netView Stock
REAL-TIME FEEDTERMINAL PAGE 21